These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The interplay between neutrophils, complement, and microthrombi in COVID-19. Zuo Y; Kanthi Y; Knight JS; Kim AHJ Best Pract Res Clin Rheumatol; 2021 Mar; 35(1):101661. PubMed ID: 33526325 [TBL] [Abstract][Full Text] [Related]
3. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Iba T; Connors JM; Levy JH Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567 [TBL] [Abstract][Full Text] [Related]
4. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B Front Immunol; 2021; 12():627579. PubMed ID: 33692801 [TBL] [Abstract][Full Text] [Related]
5. Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation. Ekdahl KN; Teramura Y; Hamad OA; Asif S; Duehrkop C; Fromell K; Gustafson E; Hong J; Kozarcanin H; Magnusson PU; Huber-Lang M; Garred P; Nilsson B Immunol Rev; 2016 Nov; 274(1):245-269. PubMed ID: 27782319 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis. Bhargavan B; Kanmogne GD Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345 [TBL] [Abstract][Full Text] [Related]
7. Thromboinflammation: From Atherosclerosis to COVID-19. Wagner DD; Heger LA Arterioscler Thromb Vasc Biol; 2022 Sep; 42(9):1103-1112. PubMed ID: 35861953 [TBL] [Abstract][Full Text] [Related]
8. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. Caillon A; Trimaille A; Favre J; Jesel L; Morel O; Kauffenstein G J Thromb Haemost; 2022 Jan; 20(1):17-31. PubMed ID: 34672094 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems. Savitt AG; Manimala S; White T; Fandaros M; Yin W; Duan H; Xu X; Geisbrecht BV; Rubenstein DA; Kaplan AP; Peerschke EI; Ghebrehiwet B Front Immunol; 2021; 12():767347. PubMed ID: 34804054 [TBL] [Abstract][Full Text] [Related]
10. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis. Gando S; Wada T Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Lim MS; Mcrae S Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652 [TBL] [Abstract][Full Text] [Related]
13. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Mastellos DC; Pires da Silva BGP; Fonseca BAL; Fonseca NP; Auxiliadora-Martins M; Mastaglio S; Ruggeri A; Sironi M; Radermacher P; Chrysanthopoulou A; Skendros P; Ritis K; Manfra I; Iacobelli S; Huber-Lang M; Nilsson B; Yancopoulou D; Connolly ES; Garlanda C; Ciceri F; Risitano AM; Calado RT; Lambris JD Clin Immunol; 2020 Nov; 220():108598. PubMed ID: 32961333 [TBL] [Abstract][Full Text] [Related]
14. The role of platelets, neutrophils and endothelium in COVID-19 infection. Falcinelli E; Petito E; Gresele P Expert Rev Hematol; 2022 Aug; 15(8):727-745. PubMed ID: 35930267 [TBL] [Abstract][Full Text] [Related]
15. Patients with COVID-19: in the dark-NETs of neutrophils. Ackermann M; Anders HJ; Bilyy R; Bowlin GL; Daniel C; De Lorenzo R; Egeblad M; Henneck T; Hidalgo A; Hoffmann M; Hohberger B; Kanthi Y; Kaplan MJ; Knight JS; Knopf J; Kolaczkowska E; Kubes P; Leppkes M; Mahajan A; Manfredi AA; Maueröder C; Maugeri N; Mitroulis I; Muñoz LE; Narasaraju T; Naschberger E; Neeli I; Ng LG; Radic MZ; Ritis K; Rovere-Querini P; Schapher M; Schauer C; Simon HU; Singh J; Skendros P; Stark K; Stürzl M; van der Vlag J; Vandenabeele P; Vitkov L; von Köckritz-Blickwede M; Yanginlar C; Yousefi S; Zarbock A; Schett G; Herrmann M Cell Death Differ; 2021 Nov; 28(11):3125-3139. PubMed ID: 34031543 [TBL] [Abstract][Full Text] [Related]
16. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19. Ding J; Hostallero DE; El Khili MR; Fonseca GJ; Milette S; Noorah N; Guay-Belzile M; Spicer J; Daneshtalab N; Sirois M; Tremblay K; Emad A; Rousseau S PLoS Comput Biol; 2021 Mar; 17(3):e1008810. PubMed ID: 33684134 [TBL] [Abstract][Full Text] [Related]
18. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond. Zhu Y; Chen X; Liu X Front Immunol; 2022; 13():838011. PubMed ID: 35309344 [TBL] [Abstract][Full Text] [Related]
19. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation. Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]